Latest News
-
Press ReleasesJune 25, 2025For the first time in U.S. history, Centrus Energy Corp has produced 900 kilograms of high-assay low-enriched uranium (HALEU), a crucial fuel source needed by most advanced reactor designs.Office of Nuclear Energy
-
June 24, 2025Jay D. Keasling, a Senior Faculty Scientist at Lawrence Berkeley National Laboratory has been named the 2025 OTC/NAI Innovator of the Year.Office of Technology Commercialization
-
Press ReleasesJune 24, 2025The Department of Energy (DOE) today issued an emergency order authorized by Section 202(c) of the Federal Power Act to address potential grid shortfall issues in the Southeast U.S.Energy.gov
-
Press ReleasesJune 24, 2025NNSA achieved a key milestone in energizing the Uranium Processing Facility (UPF) at the Y-12 National Security Complex in Oak Ridge, Tennessee, signifying the project’s transition to the final phase of construction.National Nuclear Security Administration
-
June 24, 2025Results from the first-of-a-kind experiment at Idaho National Laboratory could help boost performance and reduce waste generated at nuclear power plants across the country.Office of Nuclear Energy
-
June 24, 2025A long-running project from CESER, cybersecurity companies Bastazo and Network Perception, and a team from the University of Arkansas produced software that gives energy utilities a sophisticated way of assessing their system’s security vulnerabilities.Office of Cybersecurity, Energy Security, and Emergency Response
-
June 20, 2025Today’s action disburses $100,451,904 of the up to $1.52 billion loan guarantee to Holtec for the Palisades Nuclear Plant.Energy.gov
-
June 18, 2025New pilot program unlocks private funding and provides fast track to commercial licensingEnergy.gov
-
Press ReleasesJune 18, 2025The FY2026 Budget delivers on President Trump’s directive to restore American energy dominance, unleash every American energy advantage, and bring commonsense back to Washington.Energy.gov
-
June 18, 2025National laboratories’ accelerator-produced Ac-225 to be used in an FDA-approved targeted cancer therapy clinical trial for the first timeOffice of Science